29 September 2009 -- Actavis Group, the international generic pharmaceuticals company, today announced the launch of the antiepileptic drug Topiramate in the UK, Germany, France and Switzerland. The product was launched on day one as the originator's patent expired on 25 September. Actavis was first to market in all four countries.
The details can be read here.
No comments:
Post a Comment